Literature DB >> 6434335

Evidence that inhibition of medial preoptic dopaminergic activity may be involved in the prepubertal desensitization to the negative oestrogen feedback in female rats.

P Gerber, F Döcke, W Rohde, G Dörner.   

Abstract

Immature female rats were bilaterally lesioned in the medial preoptic area (MPOA) or hypothalamic ventromedial-arcuate region (VMAR) at 21 days of age and daily injected with the dopamine (DA) agonist bromocriptine (CB-154) through day 26. Estimation of the serum LH and FSH concentrations following ovariectomy and two injections of 0.05 micrograms oestradiol benzoate (OB)/100 g b.w. revealed that the desensitization to the negative feedback effect of OB induced by lesioning of the MPOA was almost completely prevented by CB-154. A similar effect of the drug was not found in rats lesioned in the VMAR. The DA antagonist alpha-methyldopa (alpha-MD) was then bilaterally implanted in the MPOA or VMAR of 28-day-old females. Evaluation of the gonadotrophin-inhibiting effect of OB on days 30-31 showed that medial preoptic, but not hypothalamic implants of alpha-MD reduced the sensitivity to the inhibitory action of OB. It is proposed that diminution of the dopaminergic activity in the MPOA may play a role in the prepubertal desensitization to the negative oestrogen feedback in female rats.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6434335     DOI: 10.1055/s-0029-1210360

Source DB:  PubMed          Journal:  Exp Clin Endocrinol        ISSN: 0232-7384


  2 in total

1.  Dopaminergic inhibition of gonadotropin-releasing hormone neurons in the cichlid fish Astatotilapia burtoni.

Authors:  Astra S Bryant; Anna K Greenwood; Scott A Juntti; Allie E Byrne; Russell D Fernald
Journal:  J Exp Biol       Date:  2016-10-14       Impact factor: 3.312

2.  The Dopamine D4 Receptor Regulates Gonadotropin-Releasing Hormone Neuron Excitability in Male Mice.

Authors:  Leigh Dairaghi; Stephanie Constantin; Andrew Oh; David Shostak; Susan Wray
Journal:  eNeuro       Date:  2022-03-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.